Lilly Opposes Creating MDL For Cymbalta 'Brain Zap' Suits

By Kira Lerner (September 10, 2014, 2:37 PM EDT) -- Eli Lilly & Co. fired back on Tuesday at plaintiffs' attempt to centralize 28 suits in California alleging the drug company misled them about the "brain zaps" and other negative withdrawal effects they would suffer when they stopped taking antidepressant Cymbalta, telling the U.S. Judicial Panel on Multidistrict Litigation the issues are largely individual....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!